Retatrutide in Australia: A Potential Breakthrough for Obesity Management ?
Australia is eagerly anticipating the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor therapy, representing a significant advance in addressing excess weight. Early study data have demonstrated impressive results, showing greater impact than existing treatments like semaglutide.